Selected research
Industry Research
Anxiety and Panic Disorders Drugs Industry Research Report 2026
Market perspective
The global Anxiety and Panic Disorders Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anxiety and Panic Disorders Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anxiety and Panic Disorders Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anxiety and Panic Disorders Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anxiety and Panic Disorders Drugs include Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, AstraZeneca, Bristol-Myers Squibb and Azevan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anxiety and Panic Disorders Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anxiety and Panic Disorders Drugs Market by Company
Roche
Eli Lilly
Pfizer
GlaxoSmithKline
Baxter
AstraZeneca
Bristol-Myers Squibb
Azevan Pharmaceuticals
Anxiety and Panic Disorders Drugs Segment by Type
Antidepressant Drugs
Anxiolytic Drugs
Anxiety and Panic Disorders Drugs Segment by Application
Hospitals
Clinics
Anxiety and Panic Disorders Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety and Panic Disorders Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anxiety and Panic Disorders Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety and Panic Disorders Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anxiety and Panic Disorders Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anxiety and Panic Disorders Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anxiety and Panic Disorders Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antidepressant Drugs
- Anxiolytic Drugs
Applications
- Hospitals
- Clinics
Companies covered
- Roche
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Baxter
- AstraZeneca
- Bristol-Myers Squibb
- Azevan Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anxiety and Panic Disorders Drugs Market Size (2021-2032)
- 2.2.2 Global Anxiety and Panic Disorders Drugs Sales (2021-2032)
- 2.2.3 Global Anxiety and Panic Disorders Drugs Market Average Price (2021-2032)
- 2.3 Anxiety and Panic Disorders Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antidepressant Drugs
- 2.3.3 Anxiolytic Drugs
- 2.4 Anxiety and Panic Disorders Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anxiety and Panic Disorders Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anxiety and Panic Disorders Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Anxiety and Panic Disorders Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Anxiety and Panic Disorders Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Anxiety and Panic Disorders Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anxiety and Panic Disorders Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anxiety and Panic Disorders Drugs, Product Type & Application
- 3.8 Global Manufacturers of Anxiety and Panic Disorders Drugs, Established Date
- 3.9 Global Anxiety and Panic Disorders Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche Anxiety and Panic Disorders Drugs Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Anxiety and Panic Disorders Drugs Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Anxiety and Panic Disorders Drugs Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Anxiety and Panic Disorders Drugs Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Baxter
- 4.5.1 Baxter Company Information
- 4.5.2 Baxter Business Overview
- 4.5.3 Baxter Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Baxter Anxiety and Panic Disorders Drugs Product Portfolio
- 4.5.5 Baxter Recent Developments
- 4.6 AstraZeneca
- 4.6.1 AstraZeneca Company Information
- 4.6.2 AstraZeneca Business Overview
- 4.6.3 AstraZeneca Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AstraZeneca Anxiety and Panic Disorders Drugs Product Portfolio
- 4.6.5 AstraZeneca Recent Developments
- 4.7 Bristol-Myers Squibb
- 4.7.1 Bristol-Myers Squibb Company Information
- 4.7.2 Bristol-Myers Squibb Business Overview
- 4.7.3 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Product Portfolio
- 4.7.5 Bristol-Myers Squibb Recent Developments
- 4.8 Azevan Pharmaceuticals
- 4.8.1 Azevan Pharmaceuticals Company Information
- 4.8.2 Azevan Pharmaceuticals Business Overview
- 4.8.3 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Product Portfolio
- 4.8.5 Azevan Pharmaceuticals Recent Developments
5 Global Anxiety and Panic Disorders Drugs Market Scenario by Region
- 5.1 Global Anxiety and Panic Disorders Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anxiety and Panic Disorders Drugs Sales by Region: 2021-2032
- 5.2.1 Global Anxiety and Panic Disorders Drugs Sales by Region: 2021-2026
- 5.2.2 Global Anxiety and Panic Disorders Drugs Sales by Region: 2027-2032
- 5.3 Global Anxiety and Panic Disorders Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Anxiety and Panic Disorders Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Anxiety and Panic Disorders Drugs Revenue by Region: 2027-2032
- 5.4 North America Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
- 5.4.1 North America Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anxiety and Panic Disorders Drugs Sales by Country (2021-2032)
- 5.4.3 North America Anxiety and Panic Disorders Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
- 5.5.1 Europe Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anxiety and Panic Disorders Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Anxiety and Panic Disorders Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anxiety and Panic Disorders Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anxiety and Panic Disorders Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
- 5.7.1 South America Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anxiety and Panic Disorders Drugs Sales by Country (2021-2032)
- 5.7.3 South America Anxiety and Panic Disorders Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anxiety and Panic Disorders Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Anxiety and Panic Disorders Drugs Sales by Type (2021-2032)
- 6.1.1 Global Anxiety and Panic Disorders Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Anxiety and Panic Disorders Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Anxiety and Panic Disorders Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Anxiety and Panic Disorders Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anxiety and Panic Disorders Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Anxiety and Panic Disorders Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anxiety and Panic Disorders Drugs Sales by Application (2021-2032)
- 7.1.1 Global Anxiety and Panic Disorders Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Anxiety and Panic Disorders Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Anxiety and Panic Disorders Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Anxiety and Panic Disorders Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anxiety and Panic Disorders Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Anxiety and Panic Disorders Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anxiety and Panic Disorders Drugs Value Chain Analysis
- 8.1.1 Anxiety and Panic Disorders Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anxiety and Panic Disorders Drugs Production Mode & Process
- 8.2 Anxiety and Panic Disorders Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anxiety and Panic Disorders Drugs Distributors
- 8.2.3 Anxiety and Panic Disorders Drugs Customers
9 Global Anxiety and Panic Disorders Drugs Analyzing Market Dynamics
- 9.1 Anxiety and Panic Disorders Drugs Industry Trends
- 9.2 Anxiety and Panic Disorders Drugs Industry Drivers
- 9.3 Anxiety and Panic Disorders Drugs Industry Opportunities and Challenges
- 9.4 Anxiety and Panic Disorders Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst